Works by Greipp, Patricia
Results: 105
Predictors of Local Control With Palliative Radiotherapy for Multiple Myeloma.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2025, v. 25, n. 3, p. 212, doi. 10.1016/j.clml.2024.10.004
- By:
- Publication type:
- Article
Real-life sensitivity of flow cytometry minimal residual disease assessment for plasma cell neoplasms.
- Published in:
- 2024
- By:
- Publication type:
- Letter
Unraveling the genomic underpinnings of unbalanced MYC break-apart FISH results using whole genome sequencing analysis.
- Published in:
- Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00967-8
- By:
- Publication type:
- Article
Prospective evaluation of genome sequencing to compare conventional cytogenetics in acute myeloid leukemia.
- Published in:
- Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00908-5
- By:
- Publication type:
- Article
Conditional survival in multiple myeloma and impact of prognostic factors over time.
- Published in:
- Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00852-4
- By:
- Publication type:
- Article
Utility of flow cytometry screening before MRD testing in multiple myeloma.
- Published in:
- Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00832-8
- By:
- Publication type:
- Article
TP53 mutation variant allele frequency of ≥10% is associated with poor prognosis in therapy-related myeloid neoplasms.
- Published in:
- Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00821-x
- By:
- Publication type:
- Article
Observation and treatment in DDX41-mutated acute myeloid leukemia and myelodysplastic syndrome.
- Published in:
- Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00818-6
- By:
- Publication type:
- Article
Conditional survival in multiple myeloma and impact of prognostic factors over time.
- Published in:
- Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00852-4
- By:
- Publication type:
- Article
Utility of flow cytometry screening before MRD testing in multiple myeloma.
- Published in:
- 2023
- By:
- Publication type:
- Letter
TP53 mutation variant allele frequency of ≥10% is associated with poor prognosis in therapy-related myeloid neoplasms.
- Published in:
- Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00821-x
- By:
- Publication type:
- Article
Observation and treatment in DDX41-mutated acute myeloid leukemia and myelodysplastic syndrome.
- Published in:
- 2023
- By:
- Publication type:
- Letter
Pure (acute) erythroid leukemia: morphology, immunophenotype, cytogenetics, mutations, treatment details, and survival data among 41 Mayo Clinic cases.
- Published in:
- Blood Cancer Journal, 2022, v. 12, n. 11, p. 1, doi. 10.1038/s41408-022-00746-x
- By:
- Publication type:
- Article
Therapy-related myeloid neoplasms following chimeric antigen receptor T-cell therapy for Non-Hodgkin Lymphoma.
- Published in:
- 2022
- By:
- Publication type:
- Letter
Unique characteristics and outcomes of therapy-related acute lymphoblastic leukemia following treatment for multiple myeloma.
- Published in:
- Blood Cancer Journal, 2022, v. 12, n. 6, p. 1, doi. 10.1038/s41408-022-00680-y
- By:
- Publication type:
- Article
A simple additive staging system for newly diagnosed multiple myeloma.
- Published in:
- Blood Cancer Journal, 2022, v. 12, n. 1, p. 1, doi. 10.1038/s41408-022-00611-x
- By:
- Publication type:
- Article
Myeloid malignancies in cancer patients treated with poly(ADP-ribose) polymerase (PARP) inhibitors: a case series.
- Published in:
- 2022
- By:
- Publication type:
- Letter
MYC break-apart FISH probe set reveals frequent unbalanced patterns of uncertain significance when evaluating aggressive B-cell lymphoma.
- Published in:
- 2021
- By:
- Publication type:
- Letter
Identification of adult Philadelphia-like acute lymphoblastic leukemia using a FISH‐based algorithm distinguishes prognostic groups and outcomes.
- Published in:
- 2021
- By:
- Publication type:
- Letter
Clinical and biological characteristics and prognostic impact of somatic GATA2 mutations in myeloid malignancies: a single institution experience.
- Published in:
- 2021
- By:
- Publication type:
- Letter to the Editor
Treatment outcome of clonal cytopenias of undetermined significance: a single-institution retrospective study.
- Published in:
- 2021
- By:
- Publication type:
- Letter
Cytogenetic abnormalities in multiple myeloma: association with disease characteristics and treatment response.
- Published in:
- Blood Cancer Journal, 2020, v. 10, n. 8, p. N.PAG, doi. 10.1038/s41408-020-00348-5
- By:
- Publication type:
- Article
Mate pair sequencing outperforms fluorescence in situ hybridization in the genomic characterization of multiple myeloma.
- Published in:
- Blood Cancer Journal, 2019, v. 9, n. 12, p. 1, doi. 10.1038/s41408-019-0255-z
- By:
- Publication type:
- Article
Characterization of TCF3 rearrangements in pediatric B-lymphoblastic leukemia/lymphoma by mate-pair sequencing (MPseq) identifies complex genomic rearrangements and a novel TCF3/TEF gene fusion.
- Published in:
- Blood Cancer Journal, 2019, v. 9, n. 10, p. N.PAG, doi. 10.1038/s41408-019-0239-z
- By:
- Publication type:
- Article
Amplification of 9p24.1 in diffuse large B-cell lymphoma identifies a unique subset of cases that resemble primary mediastinal large B-cell lymphoma.
- Published in:
- Blood Cancer Journal, 2019, v. 9, n. 9, p. N.PAG, doi. 10.1038/s41408-019-0233-5
- By:
- Publication type:
- Article
IBCL-085: Assessment of Fixed-Duration Therapies for Treatment-Naïve Waldenström Macroglobulinemia.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S401, doi. 10.1016/S2152-2650(21)01906-6
- By:
- Publication type:
- Article
Poster: IBCL-085: Assessment of Fixed-Duration Therapies for Treatment-Naïve Waldenström Macroglobulinemia.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S244, doi. 10.1016/S2152-2650(21)01536-6
- By:
- Publication type:
- Article
Oral Abstract: IBCL-085: Assessment of Fixed-Duration Therapies for Treatment-Naïve Waldenström Macroglobulinemia.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S203, doi. 10.1016/S2152-2650(21)01277-5
- By:
- Publication type:
- Article
Dual Primary IGH Translocations in Multiple Myeloma: A Novel Finding.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, n. 9, p. e710, doi. 10.1016/j.clml.2021.05.001
- By:
- Publication type:
- Article
Mate pair sequencing outperforms fluorescence in situ hybridization and improves diagnostic yield in the genomic characterization of multiple myeloma.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e58, doi. 10.1016/j.clml.2019.09.090
- By:
- Publication type:
- Article
Whole Genome Mate-pair Sequencing of Plasma Cell Neoplasm as a Novel Diagnostic Strategy: A Case of Unrecognized t(2;11) Structural Variation.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Clonal heterogeneity in STAG2m myeloid neoplasms: the Mayo Clinic experience.
- Published in:
- 2024
- By:
- Publication type:
- Letter
Co-mutational pattern of somatic GATA2-mutated myeloid neoplasms.
- Published in:
- Annals of Hematology, 2023, v. 102, n. 1, p. 211, doi. 10.1007/s00277-022-05016-1
- By:
- Publication type:
- Article
Autoimmune manifestations in STAG2-mutated myeloid neoplasms.
- Published in:
- Annals of Hematology, 2022, v. 101, n. 12, p. 2785, doi. 10.1007/s00277-022-04995-5
- By:
- Publication type:
- Article
Impact of marrow blasts percentage on high-grade myelodysplastic syndrome assessed using revised international prognostic scoring system.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Evaluation of Novel Targets, Including CC-Chemokine Receptor 4, in Adult T-Cell Acute Lymphoblastic Leukemia/Lymphoma: A Mayo Clinic Clinical and Pathologic Study.
- Published in:
- Archives of Pathology & Laboratory Medicine, 2024, v. 148, n. 4, p. 471, doi. 10.5858/arpa.2022-0482-OA
- By:
- Publication type:
- Article
BRAF Rearrangements and BRAF V600E Mutations Are Seen in a Subset of Pancreatic Carcinomas With Acinar Differentiation.
- Published in:
- Archives of Pathology & Laboratory Medicine, 2022, v. 146, n. 7, p. 840, doi. 10.5858/arpa.2020-0739-OA
- By:
- Publication type:
- Article
Systematic use of fluorescence in‐situ hybridisation and clinicopathological features in the screening of PDGFRB rearrangements of patients with myeloid/lymphoid neoplasms.
- Published in:
- Histopathology, 2020, v. 76, n. 7, p. 1042, doi. 10.1111/his.14097
- By:
- Publication type:
- Article
Fluorescence in‐situ hybridisation for TP63 rearrangements in T cell lymphomas: single‐site experience of 470 patients and implications for clinical testing.
- Published in:
- Histopathology, 2020, v. 76, n. 3, p. 481, doi. 10.1111/his.14005
- By:
- Publication type:
- Article
Atypical lipomatous tumour/well‐differentiated liposarcoma and de‐differentiated liposarcoma in patients aged ≤ 40 years: a study of 116 patients.
- Published in:
- Histopathology, 2019, v. 75, n. 6, p. 833, doi. 10.1111/his.13957
- By:
- Publication type:
- Article
FGFR1 and FGFR2 in fibrolamellar carcinoma.
- Published in:
- Histopathology, 2016, v. 68, n. 5, p. 686, doi. 10.1111/his.12799
- By:
- Publication type:
- Article
A TRIP11:: FLT3 gene fusion in a patient with myeloid/lymphoid neoplasm with eosinophilia and tyrosine kinase gene fusions: a case report and review of the literature.
- Published in:
- Cold Spring Harbor Molecular Case Studies, 2023, v. 9, n. 1, p. 1, doi. 10.1101/mcs.a006243
- By:
- Publication type:
- Article
Patients with chronic lymphocytic leukaemia and clonal deletion of both 17p13.1 and 11q22.3 have a very poor prognosis.
- Published in:
- British Journal of Haematology, 2013, v. 163, n. 3, p. 326, doi. 10.1111/bjh.12534
- By:
- Publication type:
- Article
Anti-CD20 monoclonal antibody therapy in multiple myeloma.
- Published in:
- British Journal of Haematology, 2008, v. 141, n. 2, p. 135, doi. 10.1111/j.1365-2141.2008.07024.x
- By:
- Publication type:
- Article
MDM2 Amplification Status in a Cohort of Well-Characterized Myxofibrosarcoma: A Clinicopathologic Analysis of 22 Tumors.
- Published in:
- International Journal of Surgical Pathology, 2024, v. 32, n. 3, p. 478, doi. 10.1177/10668969231186930
- By:
- Publication type:
- Article
Incidental Detection of TFEB -Amplified Renal Cell Carcinoma by Colocated Gene Amplification of CCND3 (6p21): A Case Report and Review of the Literature.
- Published in:
- International Journal of Surgical Pathology, 2024, v. 32, n. 3, p. 551, doi. 10.1177/10668969231185081
- By:
- Publication type:
- Article
Primary Cutaneous CD30-Positive T-Cell Lymphoproliferative Disorders with Biallelic Rearrangements of DUSP22.
- Published in:
- Journal of Investigative Dermatology, 2013, v. 133, n. 6, p. 1680, doi. 10.1038/jid.2013.22
- By:
- Publication type:
- Article
Novel NONO::TFE3 fusion and ALK co-expression identified in a subset of cutaneous microcystic/reticular schwannoma.
- Published in:
- Virchows Archiv: European Journal of Pathology, 2023, v. 483, n. 2, p. 237, doi. 10.1007/s00428-023-03605-7
- By:
- Publication type:
- Article
Rare MDM2 amplification in a fat-predominant angiomyolipoma.
- Published in:
- Virchows Archiv: European Journal of Pathology, 2020, v. 477, n. 5, p. 661, doi. 10.1007/s00428-020-02813-9
- By:
- Publication type:
- Article
BAP1 Immunostain Status in Intraocular Biopsy Specimens for Uveal Melanoma Highly Correlates with Other Prognostic Markers.
- Published in:
- Ocular Oncology & Pathology, 2022, v. 8, n. 1, p. 22, doi. 10.1159/000515858
- By:
- Publication type:
- Article